Shan Yu - Hong Kong Baptist University

基本信息

浏览量：56

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 97 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Effective Molecular Characteristics of PD-1 Inhibitor Combination Regimen As the First-Line Treatment for Chinese Patients with HER2-positive Gastric Cancer: a Real-World Retrospective Analysis Study

Lingyun Zhang, Bin Guan,Wei Li,Shan Yu,Qian Li,Yiyi Yu,Yuehong Cui, Debin Sun,Yan Wang

Translational gastroenterology and hepatology (2025): 23-23

引用0浏览0WOS引用

Novel Cancer Stem Cell Targeted Retinoid ZSH-512 Impedes Colorectal Cancer Progress Via KDM3A Mediated Epigenetic Reprogramming

Suyao Li, Wenrui Zhao,Quanlin An, Lei Wang,Mengxuan Zhu, Junjie Ni,Xuan Huang, Yudong Jiang,Min Li,Jiayun Hou,Yiyi Yu,Shan Yu, Lai Wei,Heng Jiao,Tianshu Liu,Xin Cao

The Innovationpp.100831, (2025)

引用0浏览0WOS引用

Precision Treatment Paradigm: Genomic Features and Therapeutic Implications in Mesenchymal‐epithelial Transition‐amplified Gastric Cancer

Yiyi Yu, Zhening Zhang,Mengxuan Zhu,Yu Shan,Yan Wang,Li Wei,Xuan Huang,Debin Sun, Zhao Peng,Tianshu Liu

CLINICAL AND TRANSLATIONAL DISCOVERYno. 4 (2024)

引用0浏览0引用

A Real-World Study of Active Vitamin D As a Prognostic Marker in Patients with Sarcoma

Lingyun Zhang,Wei Li, Xiao Wang,Shan Yu,Rongyuan Zhuang,Yuhong Zhou

Discover Oncologyno. 1 (2024): 1-10

引用0浏览0WOS引用

Nivolumab Plus Anlotinib Hydrochloride in Advanced Gastric Adenocarcinoma and Esophageal Squamous Cell Carcinoma: the Phase II OASIS Trial

Jing Wu,Shilong Zhang,Shan Yu, Guo An,Yi Wang,Yiyi Yu,Li Liang,Yan Wang,Xiaojing Xu,YanShi Xiong,Di Shao, Zhun Shi,Nannan Li,Jingyuan Wang, Dawei Jin,Tianshu Liu,Yuehong Cui

NATURE COMMUNICATIONSno. 1 (2024)

引用0浏览0WOSNATURE引用

Acute Coronary Syndrome in a Patient with Gastric Cancer Treated by Immune Checkpoint Inhibitor: A Case Report

Bin Guan, Lingyun Zhang,Shan Yu

Malignancy Spectrumno. 2 (2024): 136-140

引用0浏览0引用

Clinical Significance of Peripheral T-cell Receptor Repertoire Profiling and Individualized Nomograms in Patients with Gastrointestinal Cancer Treated with Anti-Programmed Death 1 Antibody

Jing Wu,Yiyi Yu,Shilong Zhang,Pengfei Zhang,Shan Yu,Wei Li,Yan Wang,Qian Li, Binbin Lu, Limeng Chen,Chonglin Luo,Haixiang Peng,Tianshu Liu,Yuehong Cui

TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2024)

引用0浏览0WOS引用

Persistent Response to Combination Treatment of Pemigatinib and Chemotherapy in a Patient with Advanced Gastric Cancer: A Case Report

Jing Wu,Yuehong Cui,Shan Yu

Malignancy Spectrumpp.217-222, (2024)

引用0浏览0引用

Tislelizumab Plus Cetuximab and Irinotecan in Refractory Microsatellite Stable and RAS Wild-Type Metastatic Colorectal Cancer: a Single-Arm Phase 2 Study

Xiaojing Xu,Luoyan Ai,Keshu Hu,Li Liang,Minzhi Lv,Yan Wang,Yuehong Cui,Wei Li,Qian Li,Shan Yu,Yi Feng,Qing Liu,Ying Yang,Jiao Zhang, Fei Xu,Yiyi Yu,Tianshu Liu

Nature Communicationsno. 1 (2024)

引用2浏览0WOSNATURE引用

Preliminary Efficacy and Safety of Fruquintinib As Maintenance Therapy after First-Line Treatment in Metastatic Colorectal Cancer (mcrc): A Multicenter, Randomized, Open-Label Clinical Trial (the FRONT Study)

Xiaojing Xu,Yiyi Yu, Qing Liu,Yan Wang,Yuehong Cui,Wei Li,Qian Li,Yi Feng,Li Liang,Shan Yu,Minzhi Lv,Tianshu Liu

Journal of Clinical Oncologyno. 3_suppl (2024): 126-126

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn